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Blood-Brain Barrier Disruption and Perivascular BetaAmyloid Accumulation in the Brain of Aged Rats with
Spontaneous Hypertension: Evaluation with Dynamic
Contrast-Enhanced Magnetic Resonance Imaging
Yu Wang, Bsc1, 2*, Ruzhi Zhang, Bsc1*, Chuanyuan Tao, MD3, Ziqian Xu, Bsc1, Wei Chen, Msc1,
Chunhua Wang, Msc1, Li Song, Bsc1, Jie Zheng, PhD4, Fabao Gao, MD, PhD1
Departments of 1Radiology and 3Neurosurgery, West China Hospital, Sichuan University, Chengdu 610041, China; 2Department of Radiology, the
Affiliated Hospital of Southwest Medical University, Luzhou 646000, China; 4Mallinckrodt Institute of Radiology, Washington University School of
Medicine, St. Louis 63110, MO, USA

Objective: Whether blood-brain barrier (BBB) disruption induced by chronic spontaneous hypertension is associated with
beta-amyloid (Aβ) accumulation in the brain remains poorly understood. The purpose of this study was to investigate the
relationship between BBB disruption and Aβ influx and accumulation in the brain of aged rats with chronic spontaneous
hypertension.
Materials and Methods: Five aged spontaneously hypertensive rats (SHRs) and five age-matched normotensive WistarKyoto (WKY) rats were studied. The volume transfer constant (Ktrans) obtained from dynamic contrast-enhanced magnetic
resonance imaging (DCE-MRI) was used to evaluate BBB permeability in the hippocampus and cortex in vivo. The BBB tight
junctions, immunoglobulin G (IgG), Aβ, and amyloid precursor protein (APP) in the hippocampus and cortex were examined
with immunohistochemistry.
Results: As compared with WKY rats, the Ktrans values in the hippocampus and cortex of the SHRs increased remarkably (0.316
± 0.027 min-1 vs. 0.084 ± 0.017 min-1, p < 0.001 for hippocampus; 0.302 ± 0.072 min-1 vs. 0.052 ± 0.047 min-1, p < 0.001
for cortex). Dramatic occludin and zonula occludens-1 losses were detected in the hippocampus and cortex of SHRs, and
obvious IgG exudation was found there. Dramatic Aβ accumulation was found and limited to the area surrounding the BBB,
without extension to other parenchyma regions in the hippocampus and cortex of aged SHRs. Alternatively, differences in
APP expression in the hippocampus and cortex were not significant.
Conclusion: Blood-brain barrier disruption is associated with Aβ influx and accumulation in the brain of aged rats with
chronic spontaneous hypertension. DCE-MRI can be used as an effective method to investigated BBB damage.
Keywords: Alzheimer’s disease; Transmembrane glycoprotein; Transfer constant; Tight junction protein

INTRODUCTION
The blood-brain barrier (BBB) is a multicellular vascular

structure made up of endothelium, pericytes, and astrocytes
that separates the central nervous system from the
peripheral blood circulation (1). It inhibits the transfer

Received August 23, 2017; accepted after revision November 23, 2017.
This study was supported by the Program of the National natural science foundation of China (No. 81520108014; 81771800) and the
Sichuan province science and technology plan project of international cooperation (No. 2017HH0045).
*These authors contributed equally to this work.
Corresponding author: Fabao Gao, MD, PhD, Department of Radiology, West China Hospital, Sichuan University, No. 37, Guoxue Lane
outside the south, Wuhou District, Chengdu 610041, China.
• Tel: (8628) 85164081 • Fax: (8628) 85422135 • E-mail: gaofabao@yahoo.com
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://
creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium,
provided the original work is properly cited.

498

Copyright © 2018 The Korean Society of Radiology

Evaluationg the Brain of Aged Rats with Spontaneous Hypertension

of substances from the blood to the brain and vice versa
and thus maintains an environment that allows neurons to
function correctly. Some of the main structures responsible
for the properties of the BBB are the tight junctions (TJs),
such as occluding (2). The TJs and their adaptor molecules
(e.g., zonula occludens-1 [ZO-1]), which link the TJs to the
cytoskeleton of endothelial cells and which are essential
for the stability and function of the BBB (3), are often
affected in the presence of acute and chronic diseases of
the brain (4). If one part of the barrier malfunctions, the
BBB is disrupted, and this may lead to extravasation and
further devastating consequences, such as neuronal damage.
Previous studies have found that BBB leakage in the brain
can be induced by spontaneous hypertension (5, 6).
The production of beta-amyloid (Aβ)−an Alzheimer’s
disease biomarker−results from the amyloidogenic processing
of the amyloid precursor protein (APP) (7, 8), which is
a ubiquitously expressed transmembrane glycoprotein
(9, 10). Physiologically, Aβ is released continuously in
soluble globular form as a product of whole body cellular
metabolism, and it circulates in the bloodstream (11).
The Aβ generated in the brain can be eliminated from the
brain by the BBB through receptor-mediated transport and
perivascular drainage via the vascular basement membrane
(12, 13). Plasma-derived Aβ can also be transferred into
the brain through a specific receptor or carrier-mediated
mechanisms. The transport of Aβ across the BBB largely
determines the concentration of Aβ in the brain (14).
Therefore, BBB dysfunction may lead to Aβ accumulation
in the brain. Previous studies have demonstrated that
hypertension is one of the most common cardiovascular
risk factors for Alzheimer’s disease (15, 16). The possible
mechanism for this may be that hypertension induces Aβ
accumulation in the brain via the following routes: 1)
increasing APP expression (17); 2) enhancing APP cleavage
(18); 3) enhancing receptor-based Aβ influx processing (15);
and 4) impairing Aβ clearance (17). However, the exact
mechanism is still unclear, and it is unknown whether Aβ
can pass through the disrupted BBB to deposit itself in the
brain of an individual with hypertension. We hypothesize
that BBB disruption is associated with Aβ influx and
accumulation in the brain of aged rats with chronic
spontaneous hypertension.
In the present study, we intended to investigate BBB
permeability changes in the hippocampus and cortex of
aged spontaneously hypertensive rats (SHRs) in vivo using
volume transfer constant (Ktrans) obtained from dynamic
kjronline.org
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contrast-enhanced magnetic resonance imaging (DCE-MRI)
(19-22). In addition, we sought to evaluate the presence of
the BBB tight junction proteins (i.e., occludin and ZO-1),
immunoglobulin G (IgG), Aβ, and APP in the hippocampus
and cortex with immunohistochemistry.

MATERIALS AND METHODS
Animals
Male SHRs that were 17 months old (male, n = 5) and
age-matched male Wistar-Kyoto (WKY) rats (n = 5) were
purchased from Dashuo Laboratory Animal Co., Ltd.,
Chengdu, China. The rats were housed in the Animal
Resources Center at West China Hospital, Sichuan University,
and they had free access to food and water. They were kept
in conditions that mimicked normal daily light and dark
cycles. All of the experimental procedures were approved by
the local animal committee of West China Hospital, Sichuan
University, Chengdu, China.
Dynamic Contrast-Enhanced Magnetic Resonance Imaging
Methods and Data Analysis
All the MRI experiments were performed using a 7T MR
scanner (Bruker BioSpec 70/30; Bruker Biospin Ettlingen,
Germany). Rats were anesthetized with a 2% isoflurane/
oxygen mixture throughout the MRI examinations. The
rats’ body temperatures were kept constant at 37°C using
a heating blanket and monitored with a rectal temperature
probe.
All the rats underwent T2-weighted imaging using a
T2 spin-echo sequence (repetition time/echo time =
4000/33 ms). The field of view was 35 × 35 mm, number
of excitation was 2, and the matrix was 256 × 256 mm.
Twenty-five 1.0-mm-thick coronal slices were acquired from
each animal. DCE-MRI and data analysis were performed
as previously described (21). A bolus of contrast agent
(Magnevist [gadopentetate dimeglumine], 0.2 mmol/kg, 10
seconds duration; BeiLu Pharmaceutical Co., Ltd., Beijing,
China) was manually injected through each rat’s caudal
vein after 10 precontrast images were acquired. A series of
120 dynamic T1 spin-echo images were acquired, with the
following parameters: repetition time/echo time, 200/10.5
ms; field of view, 30 x 30 mm; number of excitation, 3; flip
angle, 178.5 degrees; slice thickness, 2 mm; and in-plane
resolution, 234 x 234 μm/pixel.
The Ktrans value was calculated with the use of DCE@urLAB
1.0 software for Microsoft Windows 7 (Microsoft, Redmond,
499
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WA, USA; http://www.die.upm.es/im/archives/DCEurLAB/).
All data processing was performed as previously described
(21). The data analysis was performed by two independent
observers, who had five-year experience in MRI diagnosis
and were blinded to each animal’s status. Four regions of
interest (ROIs) of the right hippocampus (ROI 1 and 3) and
the cortex (ROI 2 and 4) were manually drawn on slice 1
(bregma, -3.60 mm) and slice 2 (bregma, -5.60 mm) of each
animal in accordance with the standard rat brain atlas (23),
as shown in Figure 1. Both the right and left hippocampus
and the cortex were analyzed, and the ROIs of the left
hippocampus and the cortex were manually drawn as the
ROIs of the right hippocampus and the cortex. Twenty total
slices were included for the Ktrans value analysis. For each
rat, the Ktrans value of the complete hippocampus or cortex
was calculated as the average of the Ktrans values of four
ROIs of two slices. We chose the extended Tofts model to
calculate the Ktrans value because this model includes the
parameter of the plasma volume (24).
Immunohistochemistry
The brain sections were harvested, fixed in 4%
formaldehyde, and embedded in paraffin. The sections
that contained the hippocampus and cortex in bregma
-3.60 mm was cut into 5-μm-thick slices with a sliding
microtome (CM 3000; Leica, Bensheim, Germany). Doublelabeling immunostaining was performed for occludin and
glial fibrillary acidic protein (GFAP), ZO-1 and GFAP, IgG
and GFAP, and Aβ and GFAP, respectively. Single-labeling

immunostaining was performed for APP. Details of the
primary antibodies used are given in Table 1, and details of
the immunostaining method have been described previously
(25). The slides were incubated with blocking solution (5%
normal goat serum in 0.1 M phosphate-buffered saline) for
1 hour at room temperature and then incubated overnight
at 4°C with the primary antibodies. The sections were
then incubated with secondary antibodies for 1 hour at
room temperature. The secondary antibodies used in this
experiment were Alexa Fluor 488 goat anti-chicken IgY
H&L (1:200; Abcam), Alexa Fluor 594 goat anti-chicken IgY
H&L (1:200; Abcam), and DyLight 594 goat anti-rabbit IgG
H&L (1:200; Abcam). The nuclei were counterstained with
4’,6-diamidino-2-phenylindole. The images were acquired
via a Leica AF6000 cell station (Leica, Solms, Germany).
IgG, Aβ, and APP in the right hippocampus and cortex were
evaluated by measuring selectively green or red fluorescence
intensity, which was corrected for background fluorescence
and expressed as arbitrary fluorescence units (FAU) (26).
All images were taken during the first 30 seconds of light
exposure when no fluorescence decay was detected in
preliminary studies. The data analysis was performed by two
experienced laboratory technicians, who were blinded to
each animal’s status.
Statistical Analysis
Statistical analysis was performed with the use of SPSS
for Windows, Version 20 (IBM Corp., Armonk, NY, USA).
Quantitative data were tested for normal distribution by

Fig. 1. ROI definition in right hippocampus and cortex of rats. Hippocampus was defined at bregma -3.60 mm (ROI 1) and bregma -5.60
mm (ROI 3) on coronal T2WI. Cortex was defined at bregma -3.60 mm (ROI 2) and bregma -5.60 mm (ROI 4) on coronal T2WI. R = right, ROI =
region of interest, T2WI = T2-weighted imaging
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using the Kolmogorov-Smirnov test. Normally distributed
data were expressed as a mean ± standard deviation.
Two-tailed independent-sample t tests were used for
animal age, body weight, blood pressure, Ktrans value, and
histological data comparison between the two groups. P <
0.05 indicated a significant difference in all the statistical
procedures.

RESULTS
Characteristics of Aged Spontaneously Hypertensive Rats
and Age-Matched Wistar-Kyoto Rats
The attributes of aged SHRs and age-matched WKY rats
are displayed in Table 2. As compared with age-matched
WKY rats, aged SHRs had obviously higher levels of systolic
blood pressure, diastolic blood pressure, and mean blood
pressure. The body weights of the aged SHRs were lower
than those of the age-matched WKY rats.
Blood-Brain Barrier Permeability Increase in the
Hippocampus and Cortex of Aged Spontaneously
Hypertensive Rats
Dynamic contrast-enhanced-MRI was used to evaluate
BBB permeability in the hippocampus of aged SHRs and
age-matched WKY rats in vivo. The Ktrans maps and the
values of the right hippocampus and cortex of aged SHRs
and age-matched WKY rats are shown in Figure 2. Low BBB
permeability was detected in the right hippocampus and
cortex of age-matched WKY rats (Fig. 2A, B, upper rows). By
contrast, dramatically high BBB permeability was detected

in the right hippocampus and cortex of aged SHRs (Fig. 2A,
B, lower rows). The aged SHRs had significantly higher Ktrans
values in the hippocampus (0.316 ± 0.027 min-1 vs. 0.084
± 0.017 min-1, p < 0.001) and cortex (0.302 ± 0.072 min-1
vs. 0.052 ± 0.047 min-1, p < 0.001) as compared with agematched WKY rats.
Blood-Brain Barrier Disruption in the Hippocampus and
Cortex of Aged Spontaneously Hypertensive Rats
The primary structures responsible for the properties
of the BBB are the TJs (e.g., occludin) (2). The adaptor
molecules (e.g., ZO-1) that link the TJs to the cytoskeletons
of the endothelial cells are essential for the stability and
function of the BBB (3). Therefore, occludin and ZO-1 were
used to detect the integrity of the BBB in the hippocampus
and cortex. Astrocytes extend foot processes that encircle
the abluminal side of the vessel almost completely (1).
Thus, the astrocytic process around the blood vessel was
also visualized by GFAP. In age-matched WKY rats, occludin
immunoreactivity formed a continuous and sharply defined
pattern of single or double lines marking the paracellular
clefts of adjacent endothelial cells in the hippocampus and
the cortex, as indicated by white asterisks in Figures 3A
and 4A. However, in aged SHRs, occludin immunoreactivity
in the BBB in the hippocampus and cortex disappeared,
as indicated by white arrows in Figures 3A and 4A. The
astrocytic process surrounding the blood vessels remained
continuously immunoreactive to GFAP.
The pattern of ZO-1 immunoreactivity in the hippocampus
and cortex of age-matched WKY rats was like that seen for

Table 1. Overview of Primary Antibodies Used for Immunohistochemistry
Antibody
Host
Supplier
Product No.
Dilution
Target
Occludin
Rabbit
Abcam
ab31721
1/100
Tight junction protein
Zonula occludens-1
Rabbit
Abcam
ab59720
1/100
Tight junction protein
Glial fibrillary acidic protein
Chicken
Abcam
ab4674
1/400
Astrocyte process
FITC-conjugated IgG
Rabbit
Abcam
ab6730
1/200
IgG
Aβ1-42
Rabbit
Bioss
bs-0107R
1/100
Aβ1-42 peptide
APP
Rabbit
Abcam
ab32136
1/400
APP
Aβ = beta-amyloid, APP = amyloid precursor protein, FITC = fluorescein isothiocyanate, IgG = immunoglobulin G
Table 2. Characteristics of Aged SHRs and WKY Rats
Parameters
Age (months)
Body weight (g)
Systolic blood pressure (mm Hg)
Diastolic blood pressure (mm Hg)
Mean blood pressure (mm Hg)

WKY Rats (n = 5)
17.4 ± 0.3
424.2 ± 30.9
140.6 ± 12.9
94.2 ± 4.8
109.7 ± 4.0

SHRs (n = 5)
17.6 ± 0.1
280.2 ± 19.1
203.0 ± 10.1
162.4 ± 7.7
175.9 ± 5.0

P
0.242
< 0.001
< 0.001
< 0.001
< 0.001

Values are given as mean ± standard deviation. SHRs = spontaneously hypertensive rats, WKY = Wistar-Kyoto

kjronline.org
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Fig. 2. BBB permeability increase in hippocampus and cortex of aged SHRs.

A. Hippocampus and cortex of aged SHRs and age-matched WKY rats at bregma -3.60 mm (slice 1). B. Hippocampus and cortex of aged SHRs and
age-matched WKY rats at bregma -5.60 mm (slice 2). Left column shows hippocampus and cortex on T2WI. Middle column shows Ktrans maps of
hippocampus. Right column shows Ktrans maps of cortex. Color-coded Ktrans values range between 0.0 min-1 and 3.0 min-1, with dark blue indicating
0.0 min-1, green indicating 1.5 min-1, and red indicating 3.0 min-1. C. Ktrans values of right hippocampus of aged SHRs and age-matched WKY rats.
D. Ktrans values of right cortex of aged SHRs and age-matched WKY rats. Values are expressed as mean ± standard deviation. BBB = blood-brain
barrier, Ktrans = volume transfer constant, SHRs = spontaneously hypertensive rats, WKY = Wistar-Kyoto

occludin expression and involved a continuous and sharply
defined staining along the paracellular clefts, as indicated
by white asterisks in Figures 3B and 4B. As described
previously for occludin immunoreactivity, there were
significant changes in ZO-1 expression in the hippocampus
and cortex of aged SHRs. The continuous pattern of the
paracellular expression of ZO-1 immunoreactivity in agematched WKY rats disappeared in aged SHRs, as indicated
by white arrows in Figures 3B and 4B.
Immunoglobulin Leakage and Beta-Amyloid
Accumulation in the Hippocampus and Cortex of Aged
Spontaneously Hypertensive Rats
Blood-brain barrier disruption was indicated by the IgG
positivity of the small vessel walls (17). GFAP was used
to visualize the astrocyte process surrounding the blood
vessels (1). The IgG immunoreactivity in the hippocampus
and cortex of age-matched WKY rats was detected only
within the cerebrovascular lumen, as indicated by black
asterisks in Figure 5A. By contrast, aged SHRs showed
dramatic IgG leakage and accumulation in the hippocampus
502

and cortex (Fig. 5A). In addition, IgG immunoreactivity
was particularly prevalent on the cerebral vessel walls and
in the surrounding tissues, as indicated by white arrows in
Figure 5A. The FAU values of Aβ in the hippocampus and
cortex of aged SHRs were higher than those of age-matched
WKY rats (36.644 ± 2.789 vs. 30.754 ± 1.183, p = 0.002 for
hippocampus; 35.992 ± 2.230 vs. 30.583 ± 1.646, p 0.002
for cortex), as shown in Figure 5C.
Aβ1-42 was used to detect the Aβ immunoreactivity in
the hippocampus and cortex (7). The Aβ immunoreactivity
in the hippocampus and cortex of age-matched WKY rats
was detected only within the cerebrovascular lumen, as
indicated by white asterisks in Figure 5B. By contrast,
aged SHRs showed dramatic Aβ accumulation in the
hippocampus and cortex (Fig. 5B). The Aβ immunoreactivity
was particularly prevalent on the cerebral vessel walls and
in the surrounding tissues, as indicated by white arrows in
Figure 5B. The FAU values of Aβ in the hippocampus and
cortex of aged SHRs were higher than those of age-matched
WKY rats (26.355 ± 0.973 vs. 17.829 ± 2.116, p < 0.001 for
hippocampus; 35.859 ± 8.584 vs. 20.440 ± 1.899, p = 0.004
Korean J Radiol 19(3), May/Jun 2018
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A
B
Fig. 3. Occludin and ZO-1 decrease in hippocampus of aged SHRs.

WKY
SHR

SHR

WKY

A. Occludin (red) and GFAP (green) immunoreactivity in hippocampus of age-matched WKY rats (upper row) and aged SHRs (lower row). B. ZO-1
(red) and GFAP (green) immunoreactivity in hippocampus of age-matched WKY rats (upper row) and aged SHRs (lower row). White asterisks
indicate BBB surrounded by astrocyte processes. White arrows refer to decrease of occludin or ZO-1. Bar = 50 μm. GFAP = glial fibrillary acidic
protein, ZO-1 = zonula occludens-1

A
Fig. 4. Occludin and ZO-1 decrease in cortex of aged SHRs.

B

A. Occludin (red) and GFAP (green) immunoreactivity in cortex of age-matched WKY rats (upper row) and aged SHRs (lower row). B. ZO-1 (red)
and GFAP (green) immunoreactivity in cortex of age-matched WKY rats (upper row) and aged SHRs (lower row). White asterisks indicate BBB
surrounded by astrocyte processes. White arrows refer to decrease of occludin or ZO-1. Bar = 50 μm.

for cortex), as shown in Figure 5D.
Amyloid Precursor Protein Expression in the
Hippocampus and Cortex of Aged Spontaneously
Hypertensive Rats and Age-Matched Wistar-Kyoto Rats
Amyloid precursor protein expression in the hippocampus
was evaluated with immunohistochemistry. No significant
difference in APP expression in the hippocampus and cortex
of aged SHRs and age-matched WKY rats was detected.
Representative immunofluorescent images of the pyramidal
layer in the cornu ammonis 1 subfield of the hippocampus
and the cortex were shown in Figure 6A. The FAU values of
APP in the hippocampus and cortex of aged SHRs were like
those of age-matched WKY rats (43.603 ± 3.540 vs. 44.860
± 0.725, p = 0.459 for hippocampus; 39.402 ± 1.869 vs.
40.503 ± 0.931, p = 0.272 for cortex) (Fig. 6B).

DISCUSSION
This study demonstrates for the first time that BBB
kjronline.org
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disruption is associated with Aβ influx and accumulation
in the brain of aged rats with chronic spontaneous
hypertension. We found that Aβ accumulation was limited
to the area surrounding the BBB without extension to other
parenchyma regions in the brain of aged SHRs, whereas APP
expression in the brain showed no significant results as
compared with that of age-matched WKY rats. Our results
suggest a bloodstream origin of brain Aβ accumulation
(rather than a neuronal source) for those with chronic
spontaneous hypertension.
The disruption of the TJs in the brain because of
spontaneous hypertension has been demonstrated
previously (27). However, a study that evaluated the
permeability of the BBB using a noninvasive method in
subjects with hypertension was still missing. In the present
study, we used the Ktrans values obtained from DCE-MRI
to investigate BBB permeability changes in the brain of
aged SHRs in vivo (19-21). The aged SHRs had dramatically
higher Ktrans values in the hippocampus and cortex as
compared with age-matched WKY rats, which indicated
503
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p = 0.004
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20 –
0–

B
Fig. 5. IgG leakage and Aβ accumulation in hippocampus and cortex of aged SHRs.

WKY

SHR

D

A. IgG (green) and GFAP (red) immunoreactivity in hippocampus (upper row) and cortex (lower row) of aged SHRs and age-matched WKY
rats. Black asterisks indicate cerebrovascular lumen surrounded by astrocyte processes. White arrows refer to IgG leakage and accumulation
surrounding BBB. B. Aβ (red) and GFAP (green) immunoreactivity in hippocampus (upper row) and cortex (lower row) of aged SHRs and agematched WKY rats. White asterisks indicate cerebrovascular lumen surrounded by astrocyte processes. White arrows refer to Aβ accumulation
surrounding BBB. Bar = 50 μm. C. FAU values of IgG in hippocampus and cortex of aged SHRs and age-matched WKY rats. D. FAU values of Aβ in
hippocampus and cortex of aged SHRs and age-matched WKY rats. Values are expressed as mean ± standard deviation. Aβ = beta-amyloid, DAPI =
4', 6-diamidino-2-phenylindole, FAU = fluorescence arbitrary unit, IgG = immunoglobulin G

increased BBB permeability in these animals. With the
use of immunohistochemistry, we found a dramatic loss
of occludin and ZO-1 in the hippocampus and cortex of
aged SHRs. These results were consistent with those of
a previous study (27) and confirmed the BBB disruption
in the hippocampus and cortex of aged SHRs that had
been detected by DCE-MRI. Furthermore, dramatic IgG
504

exudation and accumulation were also identified, which
directly demonstrated BBB disruption in the hippocampus
and cortex of aged SHRs. Thus, based on these findings,
we propose that DCE-MRI can be used to perform a noninvasive longitudinal assessment of an impaired BBB, which
may provide a promising diagnostic and therapeutic index
for doctors.
Korean J Radiol 19(3), May/Jun 2018
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B
Fig. 6. APP expression in hippocampus and cortex of aged SHRs and age-matched WKY rats.

A. APP immunoreactivity in hippocampus (upper row) and cortex (lower row) of aged SHRs and age-matched WKY rats. Bar = 50 μm. B. FAU
values of APP in hippocampus and cortex of aged SHRs and age-matched WKY rats. Values are expressed as mean ± standard deviation. APP =
amyloid precursor protein

The Aβ generated in the brain can be eliminated from
the brain by the BBB through receptor-mediated transport
and perivascular drainage along the vascular basement
membrane (12, 13). Plasma-derived Aβ can also be
transferred into the brain through a specific receptor or
carrier-mediated mechanisms. The transport of Aβ across
the BBB largely determines the concentration of Aβ in
the brain (14). Therefore, BBB dysfunction may lead to
Aβ accumulation in the brain. In the present study, we
found dramatic Aβ accumulation in the hippocampus and
cortex of aged SHRs. The Aβ accumulation was limited to
the area surrounding the BBB, without extension to other
parenchyma regions, which suggest a bloodstream origin
of brain Aβ accumulation (rather than a neuronal source)
for those with chronic spontaneous hypertension. Aβ
accumulation on microvessel walls with concomitant BBB
leakage in the hippocampus and cortex has been found
previously in subjects with chronic hypertension induced
by transverse aortic coarctation or angiotensin II infusion
(26); however, the integrity of the TJs in the BBB in the
hippocampus was not investigated. More recently, it has
been demonstrated that non-transgenic spontaneous
hypertension caused visible Aβ accumulation with BBB
leakage in the hippocampus of rats (17, 28). However, in
those studies, Aβ was not limited to blood vessels, which
indicated that the accumulated Aβ was not derived from
plasma. Those studies also demonstrated that stroke-prone
kjronline.org
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SHRs developed cerebral small vessel disease pathology,
which may result in a failure to clear Aβ. These results
were inconsistent with those of the present study, probably
because of the differences in the hypertension model used
and the duration of hypertension.
Amyloid precursor protein is an integral membrane protein
that is abundantly expressed in the neuronal synapses
(29). In patients with Alzheimer’s disease, its proteolysis
generates Aβ, which is the main component of amyloid
plaques. It has been reported that chronic hypertension
could increase APP expression in the brain (17), and
increased APP expression was found in 20-week-old strokeprone SHRs. Surprisingly, we did not find any significant
differences in APP expression in the hippocampus and
cortex of aged SHRs and age-matched WKY rats. This was in
line with the study that demonstrated hypertension induced
by the chronic infusion of angiotensin II into C57BL/6 mice
failed to increase APP expression in the brain (29). Different
models and durations of hypertension may help to explain
this inconsistency. Overall, the unchanged APP expressiontogether with the direct evidence of Aβ accumulation
surrounding the BBB-indicated that Aβ accumulation in the
hippocampus and cortex of aged SHRs was derived from
plasma than from the brain.
A further study with a larger number of subjects is
warranted to confirm our findings in the future. In addition,
there may have been other complications such as diabetes
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which we did not exclude but may have also led to BBB
disruption.
In the present study, we found obvious BBB disruption
with dramatic Aβ accumulation in the hippocampus and
cortex of aged SHRs. The Aβ accumulation was limited
to the area surrounding the BBB, without extension to
other parenchyma regions. Alternatively, APP expression
in the hippocampus and cortex was not significance as
compared with that of WKY rats. Our results suggest a
bloodstream origin of brain Aβ accumulation rather than a
neuronal source. These results support that BBB disruption
is associated with Aβ influx and accumulation in the
hippocampus and cortex of aged SHRs. DCE-MRI can be
used as an effective method to investigate BBB damage.
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